Hong Kong, China

Chen Gui

This inventor holds 1 USPTO granted patent. Top assignee: The Hong Kong University of Science and Technology. Active years: 2021.


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chen Gui - Innovator in Cancer Treatment Technologies

Introduction

Chen Gui is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative research and development of advanced technologies. His work focuses on the application of AIE luminogens for the visualization and treatment of cancer.

Latest Patents

Chen Gui holds a patent for "AIE luminogens for visualization and treatment of cancer." This patent encompasses various aspects of AIE luminogenic probes designed for cancer cell visualization and discrimination. It includes lysosome-targeting AIEgens for imaging and autophagy visualization, as well as highly fluorescent AIE-active theranostic agents that monitor drug distribution and exhibit anti-tumor activity against specific cancer cells. The patent also covers probes comprising AIE luminogens for cancer cell imaging and staining, along with AIE luminogens featuring clusteroluminogenic properties and their methods of preparation.

Career Highlights

Chen Gui is affiliated with The Hong Kong University of Science and Technology, where he continues to advance his research in cancer treatment technologies. His work has garnered attention for its potential impact on improving cancer diagnostics and therapeutics.

Collaborations

Chen Gui has collaborated with notable researchers in his field, including Benzhong Tang and Engui Zhao. These collaborations have further enhanced the scope and application of his innovative work.

Conclusion

Chen Gui's contributions to cancer treatment through his patented technologies highlight his role as a leading inventor in the field. His ongoing research promises to pave the way for more effective cancer therapies in the future.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…